Billed, Paid, and Reasonable Are Three Different Numbers: How a Payer Reviewer Reads a Medical Bill

A medical bill arrives in a litigation file as a single number — a total at the bottom of a ledger, a lien figure, a line in a demand package. That number is almost always the billed amount, and it is the least informative number in the entire dispute. It is the one figure that nobody inside the healthcare payment system actually treats as the price of anything.

Years on the payer side teach you the first rule quickly: a bill is not a receipt. It is an opening position. Reading it as the cost of care — or worse, as the value of care — is the most common and most expensive mistake in a medical-damages fight. There are at least four other numbers hiding behind the one printed on the page, and the gaps between them are where the case is won or lost.

The chargemaster is a list price, and almost no one pays it

The billed charge comes from the provider’s chargemaster — an internal master price list that, for historical and contracting reasons, sits far above what the service costs to deliver and far above what anyone actually pays. Chargemaster rates are not set by a market in any meaningful sense. They drift upward over time, they vary enormously between facilities for an identical service, and they function mostly as a starting point from which contracted discounts are calculated. A facility that bills $74,000 for a procedure may carry an internal cost and a contracted reimbursement that bear no visible relationship to that figure.

For a litigator this matters because the billed total is the number most likely to appear in a demand and the number least likely to survive scrutiny. When a defense reviewer sees a chargemaster figure presented as the value of the care, that is not an obstacle to them — it is an opening. The gap between billed and anything defensible is the first thing they press.

The allowed amount is the real transaction

Behind the billed charge is the allowed amount: the contracted rate the provider and the payer agreed to in advance. This is the number the payment system actually runs on. When a commercial insurer processes a claim it does not pay the chargemaster figure; it pays the allowed amount set by the network contract, and the difference between billed and allowed is written off by contract — it never changes hands and was never going to.

The paid amount is one step further in: the allowed amount minus whatever the patient owes as deductible, coinsurance, or copay. So a single line item already carries three numbers — billed, allowed, and paid — and they can differ by a factor of three or four. A trained reviewer reading the bill is mentally translating every billed figure into its allowed-amount equivalent, because that is the number that reflects what the service is worth in that market.

A bill is not a receipt. It is an opening position.

Medicare is a floor, not a market

A fourth number gets dragged into damages fights: the Medicare rate. Medicare reimbursement is built from a relative-value framework — the RBRVS for professional services, DRG weights for inpatient facility care — and is an administered price, set by formula and policy rather than by negotiation. It is useful precisely because it is stable and transparent, which makes it a clean reference floor. But it is a floor, not a measure of market value. Commercial allowed amounts typically sit well above Medicare. Treating the Medicare rate as “reasonable value” understates the number as badly as treating the chargemaster as reasonable value overstates it.

This is why a defense position anchored entirely to Medicare and a plaintiff position anchored entirely to billed charges are mirror-image errors. Both pick the number at the edge of the range because it is favorable, not because it is right.

“Reasonable value” is a legal construct — and it is jurisdiction-dependent

The number the case actually turns on is none of the above. It is the tort measure of the reasonable value of the medical services — and that measure is a legal question whose answer varies by jurisdiction. Some venues let the plaintiff put the full billed charges to the jury. Others limit recovery to the amounts actually paid or accepted in satisfaction of the bill. Others use reasonable market value. The collateral-source rule, the treatment of write-offs, and lien dynamics all push on this, and the rule in one state is not the rule in the next.

I am not a lawyer, and which measure governs a given case is counsel’s call, controlled by the venue — nothing here is legal advice. The clinical point is narrower and holds everywhere: billed, allowed, paid, Medicare, and reasonable value are five different numbers, and a credible medical-charge opinion has to say which number it is offering and on what basis, rather than collapse them into one figure and hope no one notices.

How a reviewer actually reads the bill

A payer-trained reviewer does not read a bill top to bottom for a total. They read it line by line, as a set of claims, each of which has to survive on its own. For every line the reviewer asks a compressed version of the same questions: is this service supported by the documentation, is it coded the way it was actually performed, and is the charge in line with the benchmark for that code in that geography?

That line-by-line pass is where the recurring problems surface. Unbundling — billing separately for components included in a single comprehensive code. Upcoding — a level-four office visit where the documentation supports a level three, or a region count on a manipulation the exam does not support. Duplication — the same modality billed by two concurrent providers on the same day. Over-utilization — visit counts that continued long after the documented functional plateau. Equipment billed as a purchase where the care plan supported a short rental. None of these are visible from the total. All of them are visible line by line, and each one moves the defensible figure.

The gaps are where the dispute lives

Put the numbers side by side and the structure of the fight is obvious. The plaintiff is incentivized to anchor to the billed total; the defense to anchor to paid or to Medicare; and the actual reasonable value sits in the interior, supportable at a stated market percentile against a real benchmark. The side that can articulate that interior number — benchmark named, percentile stated — controls the conversation, because it is the only position that does not look like advocacy dressed up as arithmetic.

That is the discipline behind a Medical Charge & Necessity Review: take the bill apart line by line, translate each charge into its benchmark-supported reasonable value, and state the basis. For a plaintiff team it produces a substantiated floor for the medical specials that will survive cross-examination. For a defense or carrier reader it produces a documented exposure position — the difference between the billed total and the defensible figure, line by line.

The number you can defend

A reasonable-value opinion is only as good as the benchmark it names and the basis it cites. Anchored to a licensed charge-and-allowed-amount database by code and geography, with the Medicare rate as a transparent floor and a stated percentile, the figure becomes reproducible — the other side can check it and arrive at the same place. Anchored to nothing but the chargemaster, it is just the highest number on the page.

There is one more move the other side will make, and it is the subject of a companion piece: they will attack reasonableness and necessity in the same breath, because a charge for a service that was never necessary has no reasonable value at all. Those two questions are usually handled by two different people who never compare notes — and that division of labor is itself the weakness.